The role of cost-effectiveness analysis in health and medicine

JAMA

Volumn 276, Issue 14, 1996, Pages 1172-1177

  Russell, Louise B ^a   Gold, Marthe R ^b   Siegel, Joanna E ^c   Daniels, Norman ^d   Weinstein, Milton C ^c  

^a RUTGERS UNIVERSITY   (United States)

^b Office of Disease Prevention and Health Promotion   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCULATION; COST EFFECTIVENESS ANALYSIS; HEALTH; HEALTH CARE COST; MEDICINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

EID: 0029782690     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.14.1172     Document Type: Review

References (51)

1. Hadorn DC. Setting health care priorities in Oregon: cost-effectiveness meets the Rule of Rescue. JAMA. 1991;265:2218-2225.
2. Eddy DM. Oregon's methods: did cost-effectiveness analysis fail? JAMA. 1991;266:2135-2141.
3. Klevit HD, Bates AC, Castanares T, Kirk EP, Sipes-Metzler PR, Wopat R. Prioritization of health care services: a progress report by the Oregon Health Services Commission. Arch Intern Med. 1991;151:912-916.
4. Brown LD. The national politics of Oregon's rationing plan. Health Aff (Millwood). 1991;10:29-51.
5. Office of Technology Assessment. Evaluation of the Oregon Medicaid Proposal. Washington, DC: US Congress: 1991. Office of Technology Assessment publication OTA-H-531.
6. Kassirer JP, Angell M. The Journal's policy on cost-effectiveness analyses. N Engl J Med. 1994; 331:669-670.
7. Evans RG. Manufacturing consensus, marketing truth: guidelines for economic evaluation. Ann Intern Med. 1995;123:59-60.
8. Brown ML, Fintor L. Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat. 1993;25:113-118.
9. Elixhauser A, Luce BR, Taylor WR, Reblando J. Health care CBA/CEA: an update on the growth and composition of the literature. Med Care. 1993; 31(suppl):JS1-JS11.
10. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York. NY: Oxford University Press; 1996.
11. Weinstein MC. Siegel JE, Gold MR, Kamlet MS, Russell LB, for the Panel on Cost-Effectiveness in Health and Medicine. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA. In press.
12. Siegel JE, Weinstein MC, Russell LB, Gold MR, for the Panel on Cost-Effectiveness in Health and Medicine. Reporting cost-effectiveness analyses. JAMA In press.
13. Russell LB. Is Prevention Better Than Cure? Washington, DC: Brookings Institution; 1986.
14. Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology: a report on principles. Ann Intern Med. 1995;123:61-70.
15. Henry C. Economic analysis as an aid to subsidisation decisions: the development of Australia's guidelines for pharmaceuticals. PharmacoEconomics. 1992;1:54-67.
16. Canadian Coordinating Office of Health Technology Assessment (CCOHTA). Guidelines for Economic Evaluation of Pharmaceuticals. Ottawa, Ontario: Canadian Coordinating Office of Health Technology Assessment; 1994.
17. Harsanyi JC. Cardinal utility in welfare economics and in the theory of risk-taking. J Polit Econ. 1953;61:434-435.
18. Harsanyi JC. Cardinal welfare, individualistic ethics, and interpersonal comparisons of utility. J Polit Econ. 1955;63:309-321.
19. Rawls J. A Theory of Justice. Cambridge, Mass: Harvard University Press; 1971.
20. Daniels N. Just Health Care. Cambridge, Mass: Harvard University Press; 1985.
21. Daniels N. Am I My Parent's Keeper? An Essay on Justice Between the Young and the Old. New York, NY: Oxford University Press; 1988.
22. Menzel PT. Strong Medicine. New York, NY: Oxford University Press; 1992.
23. Dworkin R. What is equity? 2: equality of resources. Philos Public Aff. 1981;10:283-345.
24. Eddy DM. The individual vs society: resolving the conflict. JAMA. 1991;265:2405-2406.
25. Patrick DL, Starks HE, Cain KC, Uhlmann RF, Pearlman RA. Measuring preferences for health states worse than death. Med Decis Making. 1994; 14:9-18.
26. Proberg DG, Kane RL. Methodology for measuring health-state preferences, III: population and context effects. J Clin Epidemiol. 1989;42:585-592.
27. Patrick DL, Erickson P. Health Status and Health Policy: Allocating Resources to Health Care. New York, NY: Oxford University Press; 1993.
28. Drummond MF, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. New York, NY: Oxford University Press; 1987.
29. Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res. 1988;23:203-235.
30. The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
31. Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Operations Res. 1982;30:1043-1069.
32. Kaplan RM, Bush JW, Berry CC. The reliability, stability, and generalizability of a health status index. In: Proceedings of the Annual Meeting of the Social Statistics Section, 704-9; San Diego, Calif. Washington, DC: American Statistical Association; 1978.
33. Boyle MH, Torrance GW, Sinclair JC, Horwood SP. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med. 1983;308:1330-1337.
34. Oldridge N, Furlong W, Feeny D, et al. Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol. 1993; 72:154-161.
35. Spilker B. Quality of Life Assessment in Clinical Trials. New York, NY: Raven Press; 1990.
36. Weinstein MC, Stason WB. Hypertension: A Policy Perspective. Cambridge, Mass: Harvard University Press; 1976.
37. Balaban DJ, Sagi PC, Goldfarb NI, Nettler S. Weights for scoring the quality of well-being instrument among rheumatoid arthritics: a comparison to the general population weights. Med Care. 1986;24:973-980.
38. Llewellyn-Thomas HA, Sutherland JH, Tibshirana R, Ciampi A, Till JE, Boyd NF. Describing health states: methodologic issues in obtaining values for health states. Med Care. 1984;22:543- 552.
39. Boyle MH, Torrance GW. Developing multiattribute health indexes. Med Care. 1984;22:1045-1057.
40. Patrick DL, Sittampalam Y, Somerville S, Carter W, Bergner M. A cross-cultural comparison of health status values. Am J Public Health. 1985; 75:1402-1407.
41. Hadorn DC, Uebersax J. Large-scale outcome evaluation: how should quality of life be measured? I: calibration of a brief questionnaire and a search for preference subgroups. J Clin Epidemiol. 1995; 48:607-618.
42. Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis. 1978;31:697-704.
43. Najman J, Levine S. Evaluating the impact of medical care and technologies on the quality of life: a review and critique. Soc Sci Med. 1981;15: 107-115.
44. Epstein AM, Hall JA, Tognetti J, Son JH, Conant L. Using proxies to evaluate quality of life. Med Care. 1989;27(suppl):S91-S98.
45. Slevin ML, Stubbs L, Plant HJ, et al. Attitude to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990;300:1458-1460.
46. Nease RF Jr, Kneeland T, O'Connor GT, et al, for the Ischemic Heart Disease Patient Outcomes Research Team. Variation in patient utilities for outcomes of the management of chronic stable angina: implications for clinical practice guidelines. JAMA. 1995;273:1185-1190.
47. Harris J. QALYfying the value of life. J Med Ethics. 1987;13:117-123.
48. Daniels N. Rationing fairly: programmatic considerations. Bioethics. 1993;7:223-233.
49. Russell LB. Too much for too few: what cost- effectiveness tells us about prevention. In: Skelton WD, Osterweis M, eds. Promoting Community Health: The Role of the Academic Health Center. Washington, DC: Association of Academic Health Centers; 1993.
50. Russell LB. Educated Guesses: Making Policy About Medical Screening Tests. Berkeley, Calif: University of California Press and Milbank Memorial Fund; 1994.
51. Russell LB, Siegel JE, Daniels N, Gold MR, Luce BR, Mandelblatt JS. Cost-effectiveness analysis as a guide to resource allocation in health: roles and limitations. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.